Publikationen von Mäurer, Mathias

Meuth, Sven G , Bayas, Antonios , Kallmann, Boris, Linker, Ralf, Rieckmann, Peter , Wattjes, Mike P, Mäurer, Mathias und Kleinschnitz, Christoph (2022) Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4. Expert Opinion on Pharmacotherapy 23 (13), S. 1503-1510. Volltext nicht vorhanden.

Ziemssen, Tjalf, Richter, Stephan, Mäurer, Mathias, Buttmann, Mathias, Kreusel, Boris, Poehler, Anne-Maria, Lampl, Maren und Linker, Ralf A. (2022) OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in Germany. Frontiers in Neurology 13. Volltext nicht vorhanden.

Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf , Mäurer, Mathias, Aktas, Orhan, Baum, Karl, Berghoff, Martin, Bittner, Stefan, Chan, Andrew, Czaplinski, Adam, Deisenhammer, Florian, Di Pauli, Franziska, Du Pasquier, Renaud, Enzinger, Christian, Fertl, Elisabeth, Gass, Achim, Gehring, Klaus, Gobbi, Claudio, Goebels, Norbert, Guger, Michael, Haghikia, Aiden, Hartung, Hans-Peter, Heidenreich, Fedor, Hoffmann, Olaf, Kallmann, Boris, Kleinschnitz, Christoph , Klotz, Luisa, Leussink, Verena I., Leutmezer, Fritz, Limmroth, Volker, Lünemann, Jan D., Lutterotti, Andreas, Meuth, Sven G., Meyding-Lamadé, Uta, Platten, Michael, Rieckmann, Peter, Schmidt, Stephan, Tumani, Hayrettin, Weber, Frank, Weber, Martin S., Zettl, Uwe K., Ziemssen, Tjalf und Zipp, Frauke (2021) Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Therapeutic Advances in Neurological Disorders 14, S. 175628642110396. Volltext nicht vorhanden.

Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Stangel, Martin, Aktas, Orhan, Baum, Karl, Berghoff, Martin, Bittner, Stefan, Chan, Andrew, Czaplinski, Adam, Deisenhammer, Florian, Di Pauli, Franziska, Du Pasquier, Renaud, Enzinger, Christian, Fertl, Elisabeth, Gass, Achim, Gehring, Klaus, Gobbi, Claudio, Goebels, Norbert, Guger, Michael, Haghikia, Aiden, Hartung, Hans‑Peter, Heidenreich, Fedor, Hoffmann, Olaf, Hunter, Zoë R., Kallmann, Boris, Kleinschnitz, Christoph, Klotz, Luisa, Leussink, Verena, Leutmezer, Fritz, Limmroth, Volker, Lünemann, Jan D., Lutterotti, Andreas, Meuth, Sven G., Meyding-Lamadé, Uta, Platten, Michael, Rieckmann, Peter, Schmidt, Stephan, Tumani, Hayrettin, Weber, Martin S., Weber, Frank, Zettl, Uwe K., Ziemssen, Tjalf und Zipp, Frauke (2021) Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper). Der Nervenarzt 92 (8), S. 773-801. Volltext nicht vorhanden.

Meuth, Sven G., Bayas, Antonios, Kallmann, Boris, Kleinschnitz, Christoph, Linker, Ralf, Rieckmann, Peter und Mäurer, Mathias (2020) Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion. Expert Opinion on Pharmacotherapy 21 (16), S. 1965-1969. Volltext nicht vorhanden.

Karle, Viktoria, Hartung, Verena , Ivanovska, Keti, Mäurer, Mathias, Flachenecker, Peter, Pfeifer, Klaus und Tallner, Alexander (2020) The Two-Minute Walk Test in Persons with Multiple Sclerosis: Correlations of Cadence with Free-Living Walking Do Not Support Ecological Validity. International Journal of Environmental Research and Public Health 17 (23), S. 9044. Volltext nicht vorhanden.

Hartung, Verena , Sarshar, Mustafa , Karle, Viktoria, Shammas, Layal, Rashid, Asarnusch , Roullier, Paul, Eilers, Caroline, Mäurer, Mathias, Flachenecker, Peter, Pfeifer, Klaus und Tallner, Alexander (2020) Validity of Consumer Activity Monitors and an Algorithm Using Smartphone Data for Measuring Steps during Different Activity Types. International Journal of Environmental Research and Public Health 17 (24), S. 9314. Volltext nicht vorhanden.

Mäurer, Mathias, Tiel-Wilck, Klaus, Oehm, Eckard, Richter, Nils, Springer, Michael, Oschmann, Patrick, Manzel, Arndt, Hieke-Schulz, Stefanie, Zingler, Vera, Kandenwein, Julia A., Ziemssen, Tjalf und Linker, Ralf A. (2019) Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 12, S. 175628641989207. Volltext nicht vorhanden.